share_log

What's Happening With APTO Stock And SNES Stock Today?

What's Happening With APTO Stock And SNES Stock Today?

APTO股票和SNES股票今日走势如何?
Benzinga Real-time News ·  2021/03/24 22:25

Aptose Biosciences Inc (NASDAQ:APTO) shares are trading higher after the company reported fourth-quarter earnings results.

Aptose生物科学公司(纳斯达克:APTO)股价上涨,此前该公司公布了第四季度收益业绩。

Oppenheimer analyst Matthew Biegler also maintains Aptose with an Outperform and raises the price target from $8 to $9.

奥本海默分析师马修·比格勒(Matthew Biegler)也维持Aptose的强于大盘表现,并将目标价从8美元上调至9美元。

Aptose is a biotechnology company. The company develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology.

Aptose是一家生物技术公司。该公司开发有针对性的药物和个性化疗法,用于精确治疗危及生命的癌症,如急性髓系白血病、骨髓增生异常综合征和其他血液系统恶性肿瘤,以及肿瘤学疗法。

SenesTech Inc (NASDAQ:SNES) shares are trading higher after the company announced the initiation of a collaboration with Liphatech to develop a non-liquid formulation of ContraPest.

SenesTech Inc.(纳斯达克:SNES)股价上涨,此前该公司宣布与Liphatech合作开发ContraPest的非液体配方。

SenesTech is a biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets.

SenesTech是一家生物技术平台和研究公司,致力于开发通过生育控制来管理动物病虫害种群的技术。该公司为动物市场、商业市场和食品市场提供解决方案。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发